Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Manager record

Lilly Endowment Inc

Indianapolis, IN · CIK 316011 · EDGAR filings ↗

Q2 2026 Q1 2026 Q4 2025 Diff ⇄
$108.40BReported 13F value
1Positions
100.0%Top-10 weight
1.00Effective holdings
0.0%Est. turnover
+0New
−0Exits

Reported 13F portfolio value covers U.S. reportable long positions only — not cash, bonds, shorts or non-U.S. holdings. It is not assets under management.

Reported value by quarter Q4 2025 → Q2 2026
Sector exposure
Healthcare 100.0% (+0.0pp)

Share of reported common-equity value; (±pp) vs prior quarter.

The portfolio · Q2 2026
#SecurityWeightValueSharesΔ sharesHeld
1 LLY Eli Lilly and Company 100.0% $108.40B 90.38M -1.6% ▼ Trim 3+

Common-stock (SH) positions only; option lines are in the Options tab and are never netted. ✂ = change computed against split-adjusted prior shares. “Held N+” = held every quarter in our window, possibly longer.

Position age
12–4 quarters

Consecutive quarters each current position has been reported, within our data window.

Filing record
Jul 23 2026 13F-HR · period Q2 2026

$108.40B · 1 positions · View original SEC filing ↗

Apr 20 2026 13F-HR · period Q1 2026

$84.52B · 1 positions · View original SEC filing ↗

Jan 23 2026 13F-HR · period Q4 2025

$99.08B · 1 positions · View original SEC filing ↗

Oct 31 2025 13F-HR · period Q3 2025

$72.86B · 1 positions · View original SEC filing ↗

Jul 10 2025 13F-HR · period Q2 2025

$74.85B · 1 positions · View original SEC filing ↗

Provenance: All holdings parsed from this manager's 13F information tables on SEC EDGAR; values as reported, whole USD. Changes compare the latest accepted version of each quarter (amendments incorporated) on split-adjusted share counts. Reporting period: Q2 2026 · latest filing Jul 23, 2026 · Change methodology